about
Phylogeography and genetic variation of Triatoma dimidiata, the main Chagas disease vector in Central America, and its position within the genus TriatomaA 9,000-year record of Chagas' diseaseUsing the basic reproduction number to assess the effects of climate change in the risk of Chagas disease transmission in Colombia.Seasonality of Lutzomyia fairtigi (Diptera: Psychodidae: Phlebotominae), a species endemic to Eastern Colombia.The costs of preventing and treating chagas disease in ColombiaDevelopment of peptide-based lineage-specific serology for chronic Chagas disease: geographical and clinical distribution of epitope recognition.Chagas cardiomyopathy manifestations and Trypanosoma cruzi genotypes circulating in chronic Chagasic patients.International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients.Genetic Variability and Phylogenetic Relationships within Trypanosoma cruzi I Isolated in Colombia Based on Miniexon Gene SequencesImmunological identification of Trypanosoma cruzi lineages in human infection along the endemic areaMolecular epidemiology of human oral Chagas disease outbreaks in Colombia.Chagas disease in Andean countries.Molecular characterization and diagnosis of trypanosoma cruzi and T. rangeli.Genetic structure of Trypanosoma cruzi in Colombia revealed by a High-throughput Nuclear Multilocus Sequence Typing (nMLST) approach.Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study).Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.Trypanosoma (Herpetosoma) rangeli Tejera, 1920: an updated review.Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversityNew scenarios of Trypanosoma cruzi transmission in the Orinoco region of ColombiaLessons from a national survey of Chagas disease transmission risk in Colombia.Risks associated with dispersive nocturnal flights of sylvatic Triatominae to artificial lights in a model house in the northeastern plains of Colombia.Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease PatientsTriatominae-Trypanosoma cruzi/T. rangeli: Vector-parasite interactions.Towards a paradigm shift in the treatment of chronic Chagas disease.Diagnosis, management and treatment of chronic Chagas' gastrointestinal disease in areas where Trypanosoma cruzi infection is not endemic.A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI.Trypanosoma cruzi I diversity: towards the need of genetic subdivision?The identification of two Trypanosoma cruzi I genotypes from domestic and sylvatic transmission cycles in Colombia based on a single polymerase chain reaction amplification of the spliced-leader intergenic region.Characterization of two venezuelian Entamoeba histolytica strains using electrophoretic isoenzyme patterns and PCR-SHELA.Diagnosis of Entamoeba histolytica and Entamoeba dispar in clinical specimens by PCR-SHELA.Polymerase chain reaction-solution hybridization enzyme-linked immunoassay (PCR-SHELA) for the differential diagnosis of pathogenic and non-pathogenic Entamoeba histolytica.House-level risk factors for triatomine infestation in Colombia.Modelling geographic variation in the cost-effectiveness of control policies for infectious vector diseases: the example of Chagas disease.The impact of landscape transformation on the reinfestation rates of Rhodnius prolixus in the Orinoco Region, Colombia.Haplotype identification within Trypanosoma cruzi I in Colombian isolates from several reservoirs, vectors and humans.Diagnosis of amebic dysentery by detection of Entamoeba histolytica fecal antigen by an invasive strain-specific, monoclonal antibody-based enzyme-linked immunosorbent assay.A monoclonal antibody for distinction of invasive and noninvasive clinical isolates of Entamoeba histolytica.Value of microscopy in the diagnosis of dysentery associated with invasive Entamoeba histolytica.Further diagnostic use of an invasive-specific monoclonal antibody against Entamoeba histolytica.From ancient to contemporary molecular eco-epidemiology of Chagas disease in the Americas.
P50
Q21144545-5E616C65-8D0C-42BC-B24D-7CAF35D4AB35Q24621555-BF084E5A-2F8F-4185-8DB8-B1538CFC55A5Q30731874-F38DF496-2D16-4769-ACF0-C594D188466AQ33370107-3B8FE983-A5ED-494A-95BF-1BF148B62245Q33385135-BF6FCD30-22BD-496A-8C34-0154D166A38EQ33650335-CCC40531-5810-4F12-8CB9-E3D093DB0AABQ33769907-B8008BC4-081B-477D-AC68-C8C7A69C635DQ33802931-698837AF-AD08-4D8F-BCA0-939B51D6862EQ34078052-DF6D12C2-2E71-4021-BC7B-4CB9CA966720Q34422237-B283225F-E3E1-4166-AB48-7C84C3FDEC1CQ34600658-05F2AEE8-ECEF-4759-A86B-F0C5FDD9998DQ34692304-245C0745-874A-4DD2-8F3C-F9A6AFBB9C4EQ34692304-32D1D8FD-DF57-4C9D-8378-E3AD71A1542BQ34862942-3B96875A-ABE0-4D0A-8D42-B40699F8E669Q35002452-1FC89584-DF6D-46BA-9710-709A0369AABDQ35114499-4F594881-AB6C-4A39-B66E-8488CA5070B8Q35130398-F434F598-91F3-4803-99BD-861DD255FC73Q35205895-39EEF59A-37F1-47C1-94EF-2989977143B5Q35333873-A634A4C6-0AC1-47EC-84ED-3BACEB13C3C1Q35810725-099B57DB-C4C5-4E32-9371-7A8DC4EBFF15Q36142578-F0F3E595-BD22-440E-9C2F-EC59FDEB41BAQ36298386-C1879209-190E-47C3-B96E-A7268DA742B4Q36423574-26C891DA-4C6C-4382-BFE3-315CE9715F05Q37320804-7E577CF2-91F7-4D99-A0CF-37F421F0716CQ37544885-BB5EBD38-842C-4DE6-A32A-C7E016A4F132Q37616822-2F7C0ABA-5434-4DA4-BA53-A0212306B78FQ37660962-91F3FF41-34E2-4CA3-BD2C-061855721188Q37867725-C8AE36A2-A99B-4CB3-9A45-7219293610CAQ38567839-7CE50E8B-DCD1-4E5B-873B-978062D6D5FCQ38862761-E36E065D-EB97-4F00-A630-0ACFDC6C4E11Q38862766-1778C482-8B9B-42A9-82E0-F601A980C928Q38862769-AEFBBC19-562A-4FD0-B007-14416546FCB2Q38930476-3B423405-2AED-48C9-B22E-7C8D83CFF5FEQ38934460-A80777D7-27AB-4D59-AA35-995FC174DA14Q38953285-0FE7866B-2CF5-4ED6-BE1D-BF1061376D5EQ38998394-31575806-DCE7-4AF0-8994-26676BAE225CQ39027775-0F618B1C-6DF4-440D-A3DA-F9065480305BQ39027779-874495ED-FE90-452D-832F-B9931E8F3BB9Q39028152-691B0D6E-0107-4BD5-A73C-AF0BF04FE3C7Q39028161-07576572-0AA6-4245-BE54-D7E0BBBBC095
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
Felipe Guhl
@ast
Felipe Guhl
@en
Felipe Guhl
@es
Felipe Guhl
@nl
type
label
Felipe Guhl
@ast
Felipe Guhl
@en
Felipe Guhl
@es
Felipe Guhl
@nl
altLabel
F Guhl
@en
F. Guhl
@en
Felipe Guhl Nannetti
@en
Guhl F
@en
Guhl F.
@en
Guhl
@en
prefLabel
Felipe Guhl
@ast
Felipe Guhl
@en
Felipe Guhl
@es
Felipe Guhl
@nl
P2002
felipeguhl
P21
P31
P496
0000-0001-7180-7125